PEPCID AC Drug Patent Profile

✉ Email this page to a colleague

When do Pepcid Ac patents expire, and what generic alternatives are available?

Pepcid Ac is a drug marketed by J And J Consumer Inc and is included in three NDAs.

The generic ingredient in PEPCID AC is famotidine. There are eighteen drug master file entries for this compound. One hundred and forty-four suppliers are listed for this compound. Additional details are available on the famotidine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Pepcid Ac

A generic version of PEPCID AC was approved as famotidine by FRESENIUS KABI USA on April 16^th, 2001.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PEPCID AC?
What are the global sales for PEPCID AC?
What is Average Wholesale Price for PEPCID AC?

Summary for PEPCID AC

US Patents:	0
Applicants:	1
NDAs:	3
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	83
Clinical Trials:	35
Patent Applications:	7,161
What excipients (inactive ingredients) are in PEPCID AC?	PEPCID AC excipients list
DailyMed Link:	PEPCID AC at DailyMed

Drug patent expirations by year for PEPCID AC

Recent Clinical Trials for PEPCID AC

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Ohio State University Comprehensive Cancer Center	Phase 2/Phase 3
Leidos Life Sciences	Phase 2
United States Department of Defense	Phase 2

See all PEPCID AC clinical trials

Pharmacology for PEPCID AC

Drug Class	Histamine-2 Receptor Antagonist
Mechanism of Action	Histamine H2 Receptor Antagonists

US Patents and Regulatory Information for PEPCID AC

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
J And J Consumer Inc	PEPCID AC	famotidine	TABLET, CHEWABLE;ORAL	020801-001	Sep 24, 1998		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
J And J Consumer Inc	PEPCID AC	famotidine	TABLET;ORAL	020902-001	Aug 5, 1999		OTC	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
J And J Consumer Inc	PEPCID AC	famotidine	TABLET, CHEWABLE;ORAL	020801-002	Dec 17, 2007		OTC	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PEPCID AC

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
J And J Consumer Inc	PEPCID AC	famotidine	TABLET;ORAL	020902-001	Aug 5, 1999	⤷ Sign Up	⤷ Sign Up
J And J Consumer Inc	PEPCID AC	famotidine	TABLET;ORAL	020902-001	Aug 5, 1999	⤷ Sign Up	⤷ Sign Up
J And J Consumer Inc	PEPCID AC	famotidine	TABLET, CHEWABLE;ORAL	020801-001	Sep 24, 1998	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PEPCID AC

See the table below for patents covering PEPCID AC around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Canada	2079934	ENROBAGES PERMETTANT DE MASQUER LE GOUT DE COMPRIMES PHARMACEUTIQUES MACHABLES (TASTE MASK COATINGS FOR PREPARING CHEWABLE PHARMACEUTICAL TABLETS)	⤷ Sign Up
New Zealand	238131	CHEWABLE MEDICAMENT TABLETS FORMED FROM COMPRESSED COATED GRANULES; COATING IS A POLYMER BLEND MASKING TASTE AND PROVIDING SUSTAINED RELEASE	⤷ Sign Up
Japan	H04211608	IMPROVED COATED DRUG AND DEVICE AND METHOD FOR ITS PREPARATION	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for PEPCID AC

Recent Clinical Trials for PEPCID AC

Pharmacology for PEPCID AC

Make Better Decisions: Try a trial or see plans & pricing